In this review, we presume that the process of thrombus formation, as assessed in whole blood flow studies and in experimental (murine) thrombosis studies, reflects the platelet …
Y Zhuang, M Yu, S Lu - Purinergic Signalling, 2023 - Springer
Purines and their derivatives, extensively distributed in the body, act as a class of extracellular signaling molecules via a rich array of receptors, also known as purinoceptors …
I Russo, C Barale, E Melchionda, C Penna… - International Journal of …, 2023 - mdpi.com
Nitric oxide (NO) and carbon monoxide (CO) represent a pair of biologically active gases with an increasingly well-defined range of effects on circulating platelets. These gases …
M Marino, D Rizzotti, S Leonardi - Current cardiology reports, 2014 - Springer
Platelet inhibition is the main goal of ancillary pharmacologic therapy during percutaneous coronary interventions (PCI). Thienopyridines and ticagrelor are oral drugs developed for …
I Gurajala, R Gopinath - Annals of cardiac anaesthesia, 2016 - journals.lww.com
As the number of percutaneous coronary interventions increase annually, patients with intracoronary stents (ICS) who present for noncardiac surgery (NCS) are also on the rise …
L Zhang, J Lu, W Dong, H Tian, W Feng… - Journal of …, 2017 - journals.lww.com
Aims: New P2Y 12 adenosine diphosphate receptor antagonists have been used in the treatment of acute coronary syndrome (ACS) with different results. This systematic review …
E Tamborini Permunian, N Riva, L Guasti… - Expert Opinion on …, 2015 - Taylor & Francis
Introduction: Dual antiplatelet therapy is the standard of care for patients with acute coronary syndromes or with recent coronary stents implantation. P2Y12 receptor antagonists have …
M Jia, Z Li, H Chu, L Li, K Chen - Medical Science Monitor …, 2015 - ncbi.nlm.nih.gov
Background Whether prasugrel can take the place of clopidogrel for patients with acute coronary syndrome (ACS) is not clear. The aim of this study was to perform a meta-analysis …
V Monica, G Biondi-Zoccai, V Poonam - JACC: Advances, 2023 - pmc.ncbi.nlm.nih.gov
Scientific research is complementary to clinical activity and can be beneficial for both cardiovascular trainees and established cardiologists. Research forces clinicians to think …